185 related articles for article (PubMed ID: 14978236)
1. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists.
Bullock CM; Li JD; Zhou QY
Mol Pharmacol; 2004 Mar; 65(3):582-8. PubMed ID: 14978236
[TBL] [Abstract][Full Text] [Related]
2. Cytokine properties of prokineticins.
Monnier J; Samson M
FEBS J; 2008 Aug; 275(16):4014-21. PubMed ID: 18647349
[TBL] [Abstract][Full Text] [Related]
3. Bv8/Prokineticin proteins and their receptors.
Negri L; Lattanzi R; Giannini E; Melchiorri P
Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
[TBL] [Abstract][Full Text] [Related]
4. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors.
Masuda Y; Takatsu Y; Terao Y; Kumano S; Ishibashi Y; Suenaga M; Abe M; Fukusumi S; Watanabe T; Shintani Y; Yamada T; Hinuma S; Inatomi N; Ohtaki T; Onda H; Fujino M
Biochem Biophys Res Commun; 2002 Apr; 293(1):396-402. PubMed ID: 12054613
[TBL] [Abstract][Full Text] [Related]
5. Biological function of prokineticins.
Zhou QY; Meidan R
Results Probl Cell Differ; 2008; 46():181-99. PubMed ID: 18202926
[TBL] [Abstract][Full Text] [Related]
6. Expression of Bv8 in Pichia pastoris to identify structural features for receptor binding.
Miele R; Lattanzi R; Bonaccorsi di Patti MC; Paiardini A; Negri L; Barra D
Protein Expr Purif; 2010 Sep; 73(1):10-4. PubMed ID: 20412858
[TBL] [Abstract][Full Text] [Related]
7. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
[TBL] [Abstract][Full Text] [Related]
8. Prokineticins: novel mediators of inflammatory and contractile pathways at parturition?
Catalano RD; Lannagan TR; Gorowiec M; Denison FC; Norman JE; Jabbour HN
Mol Hum Reprod; 2010 May; 16(5):311-9. PubMed ID: 20172976
[TBL] [Abstract][Full Text] [Related]
9. Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteine-containing target peptides.
van den Berk LC; Landi E; Harmsen E; Dente L; Hendriks WJ
FEBS J; 2005 Jul; 272(13):3306-16. PubMed ID: 15978037
[TBL] [Abstract][Full Text] [Related]
10. Prokineticins in central and peripheral control of human reproduction.
Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
[TBL] [Abstract][Full Text] [Related]
11. Single proline residues can dictate the oxidative folding pathways of cysteine-rich peptides.
Boulègue C; Milbradt AG; Renner C; Moroder L
J Mol Biol; 2006 May; 358(3):846-56. PubMed ID: 16530224
[TBL] [Abstract][Full Text] [Related]
12. The variable C-terminal extension of G-protein-coupled receptor kinase 6 constitutes an accessorial autoregulatory domain.
Vatter P; Stoesser C; Samel I; Gierschik P; Moepps B
FEBS J; 2005 Dec; 272(23):6039-51. PubMed ID: 16302968
[TBL] [Abstract][Full Text] [Related]
13. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
[TBL] [Abstract][Full Text] [Related]
14. Prokineticin receptors in cardiovascular function: foe or friend?
Nebigil CG
Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
[TBL] [Abstract][Full Text] [Related]
15. Prokineticins and the heart: diverging actions elicited by signalling through prokineticin receptor-1 or -2.
Attramadal H
Cardiovasc Res; 2009 Jan; 81(1):3-4. PubMed ID: 19008213
[No Abstract] [Full Text] [Related]
16. Prokineticins in angiogenesis and cancer.
Monnier J; Samson M
Cancer Lett; 2010 Oct; 296(2):144-9. PubMed ID: 20633984
[TBL] [Abstract][Full Text] [Related]
17. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor.
Lin DC; Bullock CM; Ehlert FJ; Chen JL; Tian H; Zhou QY
J Biol Chem; 2002 May; 277(22):19276-80. PubMed ID: 11886876
[TBL] [Abstract][Full Text] [Related]
18. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
19. Role of extracellular domains in PBAN/pyrokinin GPCRs from insects using chimera receptors.
Choi MY; Fuerst EJ; Rafaeli A; Jurenka R
Insect Biochem Mol Biol; 2007 Apr; 37(4):296-306. PubMed ID: 17368193
[TBL] [Abstract][Full Text] [Related]
20. Mediating molecular recognition by methionine oxidation: conformational switching by oxidation of methionine in the carboxyl-terminal domain of calmodulin.
Anbanandam A; Bieber Urbauer RJ; Bartlett RK; Smallwood HS; Squier TC; Urbauer JL
Biochemistry; 2005 Jul; 44(27):9486-96. PubMed ID: 15996103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
